Replies to post #14648 on GTC Biotherapeutics (fka GTCB)

[vinmantoo]

oldberkeley,

Thanks for making me laugh again with another of your great cartoons.

I don't think cutting costs would be considered a negative for GTCB when the amount of cash on hand is a major issue. Newbury is full of crap when he just says GTCB will not run out of money but doesn't talk about beign concerned about finances or that cost cutting is being considered as a stop gap measure. The shame of it is that GTCB should have done it at the beginning of 2008. Just imagine if GTCB had $5 million more on hand now, or negotiated $5 million more in up front money from OVA on the US rights to rATIII.

If Cox announced he was taking his salary only in stock for the next year, and cut other top excutives salaries by dropping cash payments in exchange for stock equivalents, they could save several million dollars to solidify the company's cash position and send a strong message of confidence in GTCB.